Author： Wolffenbuttel B.H. Sels J-P. Huijberts M.S.
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.3, 2001-03, pp. : 467-478
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Barman Balfour J.A. Plosker G.L.
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :
Access to resources
Recommend
Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. :
Rosiglitazone back in the spotlight
Reactions Weekly, Vol. 1, Iss. 1309, 2010-01 ,pp. :
Pioglitazone is a Valid Alternative to Rosiglitazone
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. :
Rosiglitazone: Trials, Tribulations and Termination
Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. :